Professor Schulze-Koops’ research focuses on the cellular and molecular pathogenesis of autoimmune diseases, especially rheumatoid arthritis.

Spectrum of diseases: rheumatoid arthritis (primarily chronic polyarthritis), rheumatic diseases in childhood, osteoporosis, collagenosis, psoriatic arthritis, vasculitis, fibromyalgia syndrome (FMS), nonspecific low back pain (LBP), crystalline arthropathy, axial spondyloarthritis (axial SpA) , arthrosis.

Hendrik Schulze-Koops studied human medicine at the University of Hamburg. He received his PhD in 1988 and, after completing his internship as a physician, worked as a postdoctoral fellow in the clinical working groups for rheumatology and immunology of the Max Planck Society at the Friedrich-Alexander-University of Erlangen-Nuremberg.

In Dallas, Texas, he continued his doctoral studies at the Harold Simmons Arthritis Research Center from 1993 to 1997.

Returning to Erlangen, he worked as an assistant and led a clinical research group on the role of T cells in the pathogenesis of autoimmune diseases.

He also completed his habilitation in this subject in 2000.

Since 2003, he worked as a senior physician, and in 2006 he received the title of associate professor in clinical immunology.

Having become the head of the rheumatism department of the Medical Clinic and Clinic of the LMU, prof. Hendrik Schulze-Koops was elected President of the German Society of Rheumatology. He chaired an important specialty society in 2019 and 2020. The doctor also held two positions at the German Research Foundation (DFG).

Author of numerous articles from specialized medical publications.